Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Pfizer Inc
Pfizer Announces Operating Structure and Select Senior Leadership Posts to Be Effective Immediately Upon Close of Wyeth Acquisition
April 22nd, 2009
Pfizer (NYSE: PFE) announced the planned leadership and organizational structure for its research and commercial operations that will become effective when the Wyeth acquisition closes. The company will establish a unique research model designed to advance the strong scientific capabilities of both Pfizer and Wyeth (NYSE: WYE) and to support the new company’s nine diverse health care businesses. At the senior-most level of the organization, Pfizer will retain eight senior executives from Wyeth who will join the company post-closing. CEOs Jeff Kindler and Bernard Poussot and senior leadership of both companies continue to work closely together through...
Source: Vaccine Weekly (2009-04-22)
|
